TITAN PHARMACEUTICALS INC — Director's Dealing 2021

Feb 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP)
CIK: 0000910267
Period of Report: 2021-02-10

Reporting Person: MCNAB JAMES R (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-10	Option to Purchase Common Stock	$4.02	A	25000	Acquired	2031-02-10	Common Stock (25000)	Direct